MRK
32
2
NWS
47
2
STZ
52
3
CCI
30
2
EIX
67
5
CI
66
7
GD
60
3
CSCO
67
4
NWSA
54
2
AEE
61
3
LRCX
39
-3
SEE
46
2
CVX
32
3
DG
6
4
CNP
65
3
PX
63
3
KO
44
2
BIIB
42
-2
MAR
68
3
GWW
69
5
MRK
32
2
NWS
47
2
STZ
52
3
CCI
30
2
EIX
67
5
CI
66
7
GD
60
3
CSCO
67
4
NWSA
54
2
AEE
61
3
LRCX
39
-3
SEE
46
2
CVX
32
3
DG
6
4
CNP
65
3
PX
63
3
KO
44
2
BIIB
42
-2
MAR
68
3
GWW
69
5
Financhill
Back

Ultragenyx Pharmaceutical Vs. Perspective Therapeutics Industry Stock Comparison

Sell
38

RARE
Ultragenyx Pharmaceutical

Last Price:
56.77
Seasonality Move:
7.29%
Sell
30

CATX
Perspective Therapeutics

Last Price:
12.13
Seasonality Move:
11.55%
Sell
38
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $57.70. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $13.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $57.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $13.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.16 Buy
Relative Strength Index (14 RSI): 60.55 Buy
Chaikin Money Flow: 341109 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.2 - 58.22) Buy
Bollinger Bands (100): (41.88 - 55.9) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 47.65 Sell
Chaikin Money Flow: 430326 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.29 - 13.93) Sell
Bollinger Bands (100): (11.4 - 14.56) Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.89 Buy
20-day SMA: 55.65 Buy
50-day SMA: 55.36 Buy
200-day SMA: 47.43 Buy
8-day EMA: 55.78 Buy
20-day EMA: 55.54 Buy
50-day EMA: 54.06 Buy
200-day EMA: 48.25 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.9 Buy
20-day SMA: 12.86 Buy
50-day SMA: 13.78 Sell
200-day SMA: 12.19 Buy
8-day EMA: 12.84 Buy
20-day EMA: 13.09 Sell
50-day EMA: 13.36 Sell
200-day EMA: 11.73 Buy

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.04 per share, and an increase next year of $1.11 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):